About: Impacts of the COVID‐19 pandemic on Iranian patients with epilepsy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Impacts of the COVID‐19 pandemic on Iranian patients with epilepsy Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Impacts of the COVID‐19 pandemic on Iranian patients with epilepsy
Creator	Asadi-Pooya, Ali Bazrafshan, Mehdi Farazdaghi, Mohsen
Source	Medline; PMC
abstract	OBJECTIVE: To investigate the effects of COVID‐19 pandemic on patients’ perceptions of hardship in obtaining their drugs and if this pandemic and the social restrictions in response to that has resulted in any changes in their seizure control status. We also investigated factors potentially associated with the perceptions of difficulty in obtaining their drugs (e.g., polytherapy vs. monotherapy, taking imported drugs, and seizure status worsening). METHODS: 1. What has been your experience on obtaining your antiseizure medications in the past four weeks (compared to before)? 2. Have you experienced any changes in your seizure control status in the past four weeks? RESULTS: We included 100 patients (53 male and 47 female patients). In response to the question “Have you had any difficulties in the past 4 weeks to obtain your drugs?”, 31 people (31%) expressed hardship obtaining their drugs. In response to the question “How has been your seizure control status compared with before?”, six people (6%) expressed worsening of their seizure control status in the past 4 weeks. None of the patients reported symptoms of coronavirus infection. CONCLUSION: About one‐third of patients with epilepsy expressed significant hardship obtaining their drugs after the intensification of the COVID‐19 outbreak in Iran. The current COVID‐19 pandemic could be considered as a major shock to a nation that has already been under significant pressure (i.e., Iran).
has issue date	2020-07-06(xsd:dateTime)
bibo:doi	10.1111/ane.13310
bibo:pmid	32632917
has license	no-cc
sha1sum (hex)	163134d2f023e84643205c22e081a77855ca8364
schema:url	https://doi.org/10.1111/ane.13310
resource representing a document's title	Impacts of the COVID‐19 pandemic on Iranian patients with epilepsy
has PubMed Central identifier	PMC7362008
has PubMed identifier	32632917
schema:publication	Acta Neurol Scand
resource representing a document's body	covid:163134d2f023e84643205c22e081a77855ca8364#body_text
is schema:about of	named entity 'PANDEMIC' named entity 'MONOTHERAPY' named entity 'EFFECTS' named entity 'TAKING' named entity 'infection' named entity 'PWE' named entity 'randomly selected' named entity 'economic sanctions' named entity 'metabolic' named entity 'breakthrough seizures' named entity 'PWE' named entity 'polytherapy' named entity 'headache' named entity 'anxiety' named entity 'antiseizure medications' named entity 'SARS in 2003' named entity 'SARS' named entity 'Epilepsy' named entity 'COVID' named entity 'Iran' named entity 'Iran' named entity 'epilepsy' named entity 'pandemic' named entity 'monotherapy' named entity 'COVID-19 pandemic' named entity 'coronaviruses' named entity 'chronic medical condition' named entity 'Iran' named entity 'seizures' named entity 'focal epilepsy' named entity 'quarantine' named entity 'economic sanctions' named entity 'neurological' named entity 'Iran' named entity 'seizures' named entity 'healthcare providers' named entity 'seizure' named entity 'well-being' named entity 'COVID-19 pandemic' named entity 'coronavirus infection' named entity 'seizures' named entity 'epilepsy' named entity 'standard deviation' named entity 'people with epilepsy' named entity 'Iran' named entity 'Seizure' named entity 'Fisher's exact test' named entity 'Epilepsy' named entity 'idiopathic generalized epilepsies' named entity 'seizure' named entity 'non-adherence' named entity 'seizure' named entity 'infection' named entity 'coronavirus disease' named entity 'seizure' named entity 'social distancing measures' named entity 'Shiraz University of Medical Sciences' named entity 'seizure' named entity 'change in mental status' named entity 'seizure' named entity 'seizure' named entity 'COVID' named entity 'epilepsy' named entity 'COVID-19 outbreak' named entity 'seizure' named entity 'neurotropic' named entity 'monotherapy' named entity 'anxiety' named entity 'Shiraz University of Medical Sciences' named entity 'SARS-CoV2' named entity 'status epilepticus' named entity 'quarantine' named entity 'antiseizure' named entity 'epilepsies' named entity 'neurological' named entity 'SARS-CoV2' named entity 'COVID' named entity 'seizure' named entity 'random sample'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software